Clinical trial
Impact of Switching to Continuous Release Dopamine Agonists
NCT00465452 · University of Toledo, Other · Completed
Key facts
| NCT number | NCT00465452 |
|---|---|
| Title | Impact of Switching to Continuous Release Dopamine Agonists |
| Official title | The Impact of Switching to Continuous Release Dopamine Agonists on Non-Motor Side Effects |
| Lead sponsor | University of Toledo, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | Continuous Release Dopamine Agonists |
| Enrollment | 11 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Dec 1, 2011 |
| First posted | Apr 25, 2007 |
| Last update posted | May 16, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: